메뉴 건너뛰기




Volumn 319, Issue 2, 2018, Pages 154-164

Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012

(23)  Plevritis, Sylvia K a,b   Munoz, Diego b   Kurian, Allison W b   Stout, Natasha K c   Alagoz, Oguzhan d,e   Near, Aimee M f   Lee, Sandra J c   Van Den Broek, Jeroen J g   Huang, Xuelin c,h   Schechter, Clyde B i   Sprague, Brian L j   Song, Juhee h   De Koning, Harry J g   Trentham Dietz, Amy e   Van Ravesteyn, Nicolien T g   Gangnon, Ronald e,k,l   Chandler, Young f   Li, Yisheng h   Xu, Cong b   Ali Ergun, Mehmet d   more..


Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; TRASTUZUMAB; ERBB2 PROTEIN, HUMAN;

EID: 85040614501     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.19130     Document Type: Review
Times cited : (217)

References (42)
  • 1
    • 85040581773 scopus 로고    scopus 로고
    • Surveillance, Epidemiology, and End Results Program
    • National Cancer Institute. Accessed March 31, 2017
    • National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Breast Cancer Statistics. https://seer.cancer.gov/statfacts/html/breast.html. Accessed March 31, 2017.
    • Breast Cancer Statistics
  • 2
    • 27244434470 scopus 로고    scopus 로고
    • Effect of screening and adjuvant therapy on mortality from breast cancer
    • Berry DA, Cronin KA, Plevritis SK, et al; Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784-1792.
    • (2005) N Engl J Med , vol.353 , Issue.17 , pp. 1784-1792
    • Berry, D.A.1    Cronin, K.A.2    Plevritis, S.K.3
  • 3
    • 80054717098 scopus 로고    scopus 로고
    • Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: A cohort study
    • Kerlikowske K, Hubbard RA, Miglioretti DL, et al; Breast Cancer Surveillance Consortium. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med. 2011;155(8):493-502.
    • (2011) Ann Intern Med , vol.155 , Issue.8 , pp. 493-502
    • Kerlikowske, K.1    Hubbard, R.A.2    Miglioretti, D.L.3
  • 4
    • 84939447471 scopus 로고    scopus 로고
    • Identifying women with dense breasts at high risk for interval cancer: A cohort study
    • Kerlikowske K, Zhu W, Tosteson AN, et al; Breast Cancer Surveillance Consortium. Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med. 2015;162 (10):673-681.
    • (2015) Ann Intern Med , vol.162 , Issue.10 , pp. 673-681
    • Kerlikowske, K.1    Zhu, W.2    Tosteson, A.N.3
  • 5
    • 84905842097 scopus 로고    scopus 로고
    • Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline
    • American Society of Clinical Oncology
    • Giordano SH, Temin S, Kirshner JJ, et al; American Society of Clinical Oncology. Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014;32(19): 2078-2099.
    • (2014) J Clin Oncol , vol.32 , Issue.19 , pp. 2078-2099
    • Giordano, S.H.1    Temin, S.2    Kirshner, J.J.3
  • 6
    • 84875043185 scopus 로고    scopus 로고
    • Accessed March 31, 2017
    • National Comprehensive Cancer Network Breast Cancer Guidelines. NCCN guidelines and clinical resources. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed March 31, 2017.
    • NCCN Guidelines and Clinical Resources
  • 7
    • 85040572205 scopus 로고    scopus 로고
    • The Dana-Farber CISNET model for breast cancer screening strategies: An update
    • Lee SJ, Li X, Huang H, Zelen M. The Dana-Farber CISNET model for breast cancer screening strategies: an update. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17741634
    • (2018) Med Decis Making , vol.38 , Issue.1 s
    • Lee, S.J.1    Li, X.2    Huang, H.3    Zelen, M.4
  • 8
    • 85040597336 scopus 로고    scopus 로고
    • Simulating the impact of risk-based screening and treatment on breast cancer outcomes with MISCAN-Fadia
    • van den Broek JJ, van Ravesteyn NT, Heijnsdijk EA, de Koning H. Simulating the impact of risk-based screening and treatment on breast cancer outcomes with MISCAN-Fadia. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17711928
    • (2018) Med Decis Making , vol.38 , Issue.1 s
    • Van Den Broek, J.J.1    Van Ravesteyn, N.T.2    Heijnsdijk, E.A.3    De Koning, H.4
  • 9
    • 85040637440 scopus 로고    scopus 로고
    • Structure, function, and applications of the Georgetown-Einstein (GE) breast cancer simulation model
    • Schechter CB, Near AM, Jayasekera J, Chang Y, Mandelblatt JS. Structure, function, and applications of the Georgetown-Einstein (GE) breast cancer simulation model. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17698685
    • (2018) Med Decis Making , vol.38 , Issue.1 s
    • Schechter, C.B.1    Near, A.M.2    Jayasekera, J.3    Chang, Y.4    Mandelblatt, J.S.5
  • 10
    • 85040587865 scopus 로고    scopus 로고
    • A Bayesian simulation model for breast cancer screening, incidence, treatment, and mortality
    • Huang X, Li Y, Song J, Berry D. A Bayesian simulation model for breast cancer screening, incidence, treatment, and mortality. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17714473
    • (2018) Med Decis Making , vol.38 , Issue.1 s
    • Huang, X.1    Li, Y.2    Song, J.3    Berry, D.4
  • 11
    • 85040633992 scopus 로고    scopus 로고
    • Estimating breast cancer progression features and survival by molecular subtype in the absence of screening and treatment
    • Munoz D, Plevritis SK. Estimating breast cancer progression features and survival by molecular subtype in the absence of screening and treatment. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17743236
    • (2018) Med Decis Making , vol.38 , Issue.1 s
    • Munoz, D.1    Plevritis, S.K.2
  • 12
    • 85040538606 scopus 로고    scopus 로고
    • A molecular subtype-specific stochastic simulation model of US breast cancer incidence and mortality trends from 1975 to 2010
    • Munoz D, Xu C, Plevritis S. A molecular subtype-specific stochastic simulation model of US breast cancer incidence and mortality trends from 1975 to 2010. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17737508
    • (2018) Med Decis Making , vol.38 , Issue.1 s
    • Munoz, D.1    Xu, C.2    Plevritis, S.3
  • 13
    • 85040567016 scopus 로고    scopus 로고
    • The University of Wisconsin breast cancer epidemiology simulation model: An update
    • Alagoz O, Ergun MA, Cevik M, et al. The University of Wisconsin breast cancer epidemiology simulation model: an update. Med Decis Making. 2018;38(1s). doi:10.1177/0272989X17711927
    • (2018) Med Decis Making , vol.38 , Issue.1 s
    • Alagoz, O.1    Ergun, M.A.2    Cevik, M.3
  • 14
    • 72049091776 scopus 로고    scopus 로고
    • Effects of mammography screening under different screening schedules: Model estimates of potential benefits and harms
    • Mandelblatt JS, Cronin KA, Bailey S, et al; Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151(10):738-747.
    • (2009) Ann Intern Med , vol.151 , Issue.10 , pp. 738-747
    • Mandelblatt, J.S.1    Cronin, K.A.2    Bailey, S.3
  • 15
    • 84985004003 scopus 로고    scopus 로고
    • Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality
    • Munoz D, Near AM, van Ravesteyn NT, et al. Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality. J Natl Cancer Inst. 2014;106(11):dju289.
    • (2014) J Natl Cancer Inst , vol.106 , Issue.11 , pp. dju289
    • Munoz, D.1    Near, A.M.2    Van Ravesteyn, N.T.3
  • 16
    • 84856636292 scopus 로고    scopus 로고
    • Comparisons between different polychemotherapy regimens for early breast cancer: Meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
    • Peto R, Davies C, Godwin J, et al; Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. Lancet. 2012;379(9814):432-444.
    • (2012) Lancet , vol.379 , Issue.9814 , pp. 432-444
    • Peto, R.1    Davies, C.2    Godwin, J.3
  • 17
    • 84941767992 scopus 로고    scopus 로고
    • The contribution of mammography screening to breast cancer incidence trends in the United States: An updated age-period-cohort model
    • Gangnon RE, Sprague BL, Stout NK, et al. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model. Cancer Epidemiol Biomarkers Prev. 2015;24(6):905-912.
    • (2015) Cancer Epidemiol Biomarkers Prev , vol.24 , Issue.6 , pp. 905-912
    • Gangnon, R.E.1    Sprague, B.L.2    Stout, N.K.3
  • 20
    • 85019271426 scopus 로고    scopus 로고
    • National Cancer Institute, DCCPS, Surveillance Research Program. Released December Accessed December 14, 2017
    • Surveillance, Epidemiology, and End Results (SEER) Program. SEER∗Stat database: mortality—all COD, aggregated with state, total US (1969-2014) , National Cancer Institute, DCCPS, Surveillance Research Program. Released December 2016. https://www.seer.cancer.gov/. Accessed December 14, 2017.
    • (2016) SEER∗Stat Database: Mortality—All COD, Aggregated with State, Total US (1969-2014)
  • 21
    • 0004280716 scopus 로고    scopus 로고
    • Health Statistics. Accessed March 31, 2017
    • National Center for Health Statistics. Compressed mortality file. https://www.cdc.gov/nchs/data_access/cmf.htm. Accessed March 31, 2017.
    • Compressed Mortality File
  • 22
    • 85040578878 scopus 로고    scopus 로고
    • Common model inputs used in CISNET collaborative breast cancer modeling
    • Mandelblatt JS, Near AM, Miglioretti DL, et al. Common model inputs used in CISNET collaborative breast cancer modeling. Med Decis Making. 2018;38(1s). doi:10.1177 /0272989X17700624
    • (2018) Med Decis Making , vol.38 , Issue.1 s
    • Mandelblatt, J.S.1    Near, A.M.2    Miglioretti, D.L.3
  • 23
    • 34249105998 scopus 로고    scopus 로고
    • Additional common inputs for analyzing impact of adjuvant therapy and mammography on US mortality
    • Cronin KA, Mariotto AB, Clarke LD, Feuer EJ. Additional common inputs for analyzing impact of adjuvant therapy and mammography on US mortality. J Natl Cancer Inst Monogr. 2006;(36):26-29.
    • (2006) J Natl Cancer Inst Monogr , vol.36 , pp. 26-29
    • Cronin, K.A.1    Mariotto, A.B.2    Clarke, L.D.3    Feuer, E.J.4
  • 24
    • 23444445202 scopus 로고    scopus 로고
    • Modeling the dissemination of mammography in the United States
    • Cronin KA, Yu B, Krapcho M, et al. Modeling the dissemination of mammography in the United States. Cancer Causes Control. 2005;16(6):701-712.
    • (2005) Cancer Causes Control , vol.16 , Issue.6 , pp. 701-712
    • Cronin, K.A.1    Yu, B.2    Krapcho, M.3
  • 27
    • 0037032510 scopus 로고    scopus 로고
    • Breast cancer in the United States: 1975-1999
    • breast cancer in the United States: 1975-1999. J Natl Cancer Inst. 2002;94(21):1626-1634.
    • (2002) J Natl Cancer Inst , vol.94 , Issue.21 , pp. 1626-1634
  • 28
    • 39049180984 scopus 로고    scopus 로고
    • Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999
    • Mariotto AB, Feuer EJ, Harlan LC, Abrams J. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999. J Natl Cancer Inst Monogr. 2006;(36):7-15.
    • (2006) J Natl Cancer Inst Monogr , vol.36 , pp. 7-15
    • Mariotto, A.B.1    Feuer, E.J.2    Harlan, L.C.3    Abrams, J.4
  • 29
    • 77951441901 scopus 로고    scopus 로고
    • Accessed January 1, 2015
    • US Food and Drug Administration. Mammography Quality Standards Act and program. https://www.fda.gov/Radiation-EmittingProducts/MammographyQualityStandardsActandProgram /default.htm. Accessed January 1, 2015.
    • Mammography Quality Standards Act and Program
  • 31
    • 24644454676 scopus 로고    scopus 로고
    • The effect of changes in tumor size on breast carcinoma survival in the US: 1975-1999
    • Elkin EB, Hudis C, Begg CB, Schrag D. The effect of changes in tumor size on breast carcinoma survival in the US: 1975-1999. Cancer. 2005;104(6):1149-1157.
    • (2005) Cancer , vol.104 , Issue.6 , pp. 1149-1157
    • Elkin, E.B.1    Hudis, C.2    Begg, C.B.3    Schrag, D.4
  • 32
    • 0029933489 scopus 로고    scopus 로고
    • Breast cancer mortality rates are levelling off or beginning to decline in many western countries: Analysis of time trends, age-cohort and age-period models of breast cancer mortality in 20 countries
    • Hermon C, Beral V. Breast cancer mortality rates are levelling off or beginning to decline in many western countries: analysis of time trends, age-cohort and age-period models of breast cancer mortality in 20 countries. Br J Cancer. 1996;73(7): 955-960.
    • (1996) Br J Cancer , vol.73 , Issue.7 , pp. 955-960
    • Hermon, C.1    Beral, V.2
  • 33
    • 0034690750 scopus 로고    scopus 로고
    • UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years
    • Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet. 2000;355 (9217):1822.
    • (2000) Lancet , vol.355 , Issue.9217 , pp. 1822
    • Peto, R.1    Boreham, J.2    Clarke, M.3    Davies, C.4    Beral, V.5
  • 34
    • 84958826817 scopus 로고    scopus 로고
    • Improvements in US breast cancer survival and proportion explained by tumor size and estrogen-receptor status
    • Park JH, Anderson WF, Gail MH. Improvements in US breast cancer survival and proportion explained by tumor size and estrogen-receptor status. J Clin Oncol. 2015;33(26):2870-2876.
    • (2015) J Clin Oncol , vol.33 , Issue.26 , pp. 2870-2876
    • Park, J.H.1    Anderson, W.F.2    Gail, M.H.3
  • 35
    • 27344458270 scopus 로고    scopus 로고
    • Diagnostic performance of digital versus film mammography for breast-cancer screening
    • Pisano ED, Gatsonis C, Hendrick E, et al; Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353(17):1773-1783.
    • (2005) N Engl J Med , vol.353 , Issue.17 , pp. 1773-1783
    • Pisano, E.D.1    Gatsonis, C.2    Hendrick, E.3
  • 36
    • 84905190986 scopus 로고    scopus 로고
    • Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography
    • Stout NK, Lee SJ, Schechter CB, et al. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. J Natl Cancer Inst. 2014;106(6):dju092.
    • (2014) J Natl Cancer Inst , vol.106 , Issue.6 , pp. dju092
    • Stout, N.K.1    Lee, S.J.2    Schechter, C.B.3
  • 37
    • 84902770556 scopus 로고    scopus 로고
    • Breast cancer screening using tomosynthesis in combination with digital mammography
    • Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014;311(24):2499-2507.
    • (2014) JAMA , vol.311 , Issue.24 , pp. 2499-2507
    • Friedewald, S.M.1    Rafferty, E.A.2    Rose, S.L.3
  • 38
    • 84889257564 scopus 로고    scopus 로고
    • Digitalbreasttomosynthesis andthechallengesofimplementinganemerging breastcancerscreeningtechnologyintoclinical practice
    • LeeCI,LehmanCD
    • LeeCI,LehmanCD.Digitalbreasttomosynthesis andthechallengesofimplementinganemerging breastcancerscreeningtechnologyintoclinical practice.JAmCollRadiol.2013;10(12):913-917.
    • (2013) JAmCollRadiol , vol.10 , Issue.12 , pp. 913-917
  • 39
    • 84905163505 scopus 로고    scopus 로고
    • US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status
    • Howlader N, Altekruse SF, Li CI, et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst. 2014;106(5):dju055.
    • (2014) J Natl Cancer Inst , vol.106 , Issue.5 , pp. dju055
    • Howlader, N.1    Altekruse, S.F.2    Li, C.I.3
  • 40
    • 34249033328 scopus 로고    scopus 로고
    • Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis
    • Jatoi I, Chen BE, Anderson WF, Rosenberg PS. Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol. 2007;25(13):1683-1690.
    • (2007) J Clin Oncol , vol.25 , Issue.13 , pp. 1683-1690
    • Jatoi, I.1    Chen, B.E.2    Anderson, W.F.3    Rosenberg, P.S.4
  • 41
    • 84942239431 scopus 로고    scopus 로고
    • Estrogen receptor status and the future burden of invasive and in situ breast cancers in the United States
    • pii:djv159
    • Rosenberg PS, Barker KA, Anderson WF. Estrogen receptor status and the future burden of invasive and in situ breast cancers in the United States. J Natl Cancer Inst. 2015;107(9):pii:djv159.
    • (2015) J Natl Cancer Inst , vol.107 , Issue.9
    • Rosenberg, P.S.1    Barker, K.A.2    Anderson, W.F.3
  • 42
    • 84920973831 scopus 로고    scopus 로고
    • Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States
    • Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2): 165-173.
    • (2015) JAMA , vol.313 , Issue.2 , pp. 165-173
    • Iqbal, J.1    Ginsburg, O.2    Rochon, P.A.3    Sun, P.4    Narod, S.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.